EPGL Contact Lens Technology Chosen for Development by First Major Public Company
IRVINE, CA — (Marketwired) — 10/12/17 — (OTC: EPGL) In a first for EPGL since acquiring 100% of its ophthalmic IP portfolio, one of the world–s leading multi-billion-dollar public companies, in a brand-new relationship for EPGL, has made EPGL technology and its patented Elastic Circuit technology as the choice for a closely guarded and proprietary development of a new contact lens prototype to undergo FDA testing as early as next year. This goes beyond a right of first negotiation to now ha
